These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 7192353)

  • 1. Effects of the potential neuroleptic peptide des-tyrosine-gamma-endorphin and haloperidol on apomorphine-induced behavioural syndromes in rats and mice.
    Nickolson VJ; Berendsen HH
    Life Sci; 1980 Oct; 27(15):1377-85. PubMed ID: 7192353
    [No Abstract]   [Full Text] [Related]  

  • 2. Non-opiate beta-endorphin fragments and dopamine--II. beta-Endorphin 2-9 enhances apomorphine-induced stereotypy following subcutaneous and intra-striatal injection.
    Van Ree JM
    Neuropharmacology; 1982 Nov; 21(11):1103-9. PubMed ID: 6891031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Behavioral effects of the beta-endorphin fragment 2-9.
    van Ree JM; de Wied D
    Life Sci; 1982 Nov 15-22; 31(20-21):2383-6. PubMed ID: 6891738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-opiate beta-endorphin fragments and dopamine--I. The neuroleptic-like gamma-endorphin fragments interfere with the behavioural effects elicited by small doses of apomorphine.
    Van Ree JM; Innemee H; Louwerens JW; Kahn RS; De Wied D
    Neuropharmacology; 1982 Nov; 21(11):1095-101. PubMed ID: 6184639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opposite interactions between alpha- and beta-endorphin fragments with dopamine mediated responses on the rat rectum in vitro.
    Nijkamp FP; van Ree JM; Nijssen JG; Versluis M; de Wied D
    Naunyn Schmiedebergs Arch Pharmacol; 1982 Dec; 321(3):213-7. PubMed ID: 6185856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The hypomotility elicited by small doses of apomorphine seems exclusively mediated by dopaminergic systems in the nucleus accumbens.
    Radhakishun FS; Van Ree JM
    Eur J Pharmacol; 1987 May; 137(1):41-7. PubMed ID: 3609134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo interaction of gamma-type endorphins with dopaminergic ligands in rat brain.
    Codd EE; Scholtens H; Wolterink G; Verhoef JC; Van Ree JM; Witter A
    Eur J Pharmacol; 1983 Apr; 88(4):365-70. PubMed ID: 6861877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopamine-mediated behavior produced by the enkephalin analogue FK 33-824.
    Extein I; Lo C; Goodwin FK; Schoenfeld RI
    Psychiatry Res; 1979 Dec; 1(3):333-9. PubMed ID: 233159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of stereotypy induced by nomifensine in rats during continuous chronic haloperidol treatment.
    Rupniak NM; Jenner P; Marsden CD
    Neurosci Lett; 1984 Sep; 50(1-3):63-5. PubMed ID: 6541767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of gamma-type endorphins on alpha-MSH release in the rat.
    de Rotte AA; van Wimersma Greidanus TB; van de Buuse M; Andringa-Bakker EA; de Wied D
    Life Sci; 1985 Jul; 37(3):263-71. PubMed ID: 2409428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential liabilities of haloperidol and thioridazine for inducing apomorphine hypersensitivity.
    De Veaugh-Geiss J; Devanand DP; Carey RJ
    Biol Psychiatry; 1982 Nov; 17(11):1289-301. PubMed ID: 6891268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potentiation by Des-Tyr-gamma-endorphin on apomorphine-induced changes in rat open field behavior.
    Nickolson VJ
    Eur J Pharmacol; 1981 Jun; 72(1):77-81. PubMed ID: 7262195
    [No Abstract]   [Full Text] [Related]  

  • 13. Non-opiate beta-endorphin fragments and dopamine--VI. Behavioural analysis of the interaction between gamma-type endorphins and dopaminergic systems in the nucleus accumbens of rats.
    Király I; Van Ree JM
    Neuropharmacology; 1984 May; 23(5):511-6. PubMed ID: 6204246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of apomorphine and haloperidol on "spontaneous" stereotyped licking behaviour in the Cebus monkey.
    Korsgaard S; Povlsen UJ; Randrup A
    Psychopharmacology (Berl); 1985; 85(2):240-3. PubMed ID: 3925490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of ACTH-induced grooming by [Des-Tyr1]-gamma-endorphin and haloperidol.
    Gispen WH; Ormond D; ten Haaf J; De Wied D
    Eur J Pharmacol; 1980 May; 63(2-3):203-7. PubMed ID: 6247168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of amantadine HCl on haloperidol-induced striatal dopamine neuron hypersensitivity.
    Allen RM; Flemenbaum A
    Biol Psychiatry; 1979 Jun; 14(3):541-4. PubMed ID: 573144
    [No Abstract]   [Full Text] [Related]  

  • 17. Blockade of lergotrile or apomorphine induced turning behavior by haloperidol and clozapine.
    Nakamura S; Engel J; Goldstein M
    Commun Psychopharmacol; 1978; 2(3):185-90. PubMed ID: 29742
    [No Abstract]   [Full Text] [Related]  

  • 18. The influence of beta-LPH fragments on alpha-MSH release: the involvement of a dopaminergic system.
    de Rotte AA; van Wimersma Greidanus TB; van Ree JM; Andringa-Bakker EA; de Wied D
    Life Sci; 1981 Aug; 29(8):825-32. PubMed ID: 6170858
    [No Abstract]   [Full Text] [Related]  

  • 19. Differentiation of the central dopaminergic stimulants apomorphine and lergotrile.
    Wade RL; Krewsun I; Quock RM
    Proc West Pharmacol Soc; 1979; 22():141-2. PubMed ID: 42079
    [No Abstract]   [Full Text] [Related]  

  • 20. Electrophysiological and behavioral assessments of dopamine autoreceptor activation to apomorphine in rats.
    Okuyama S; Shimamura H; Hashimoto S; Aihara H
    Arch Int Pharmacodyn Ther; 1986 Dec; 284(2):246-54. PubMed ID: 3827410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.